Forms Processing

PRODUCTS

  • From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.

  • Compliance solutions for product development agility and audit readiness.

  • The most widely trusted solution for clinical trial disclosure management

    Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.

    Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.

  • This content was created by Boehringer Ingelheim BioXcellence™

    Microbial product market is a market with attractive growth – and that growth is coming from diverse molecule formats and process formats where Boehringer Ingelheim in Vienna has outstanding development and manufacturing experience. We’re proud to be pioneers in the microbial field, with a track record of success going back to the 1980s and our work on recombinant interferons. Since then, we have brought 20 microbial manufactured products to the global market: some our own, some as trusted manufacturing partner.

  • Natoli Scientific takes pride in its comprehensive USP<1062> Tablet Compression Characterization services, tailored to address the complexities of tableting in pharmaceutical manufacturing. Staying true to the parameters outlined in the United States Pharmacopeia (USP) Chapter 1062, our approach meticulously evaluates tablet compression behaviors. By thoroughly characterizing the compression profile, we can pinpoint the optimal compression force required to form a cohesive tablet without applying undue stress that could lead to capping — the separation of tablet tops during or after the compression phase.

WHITE PAPERS AND CASE STUDIES

NEWS